Posters
« Back
Science Talent Supply Chain Management
EP25657
Science Talent Supply Chain Management
Submitted on 31 Mar 2017

Harvey Yau & Mike Berich
KellyOCG
This poster was presented at Pittcon 2017
Poster Views: 1,090
View poster »
Poster Abstract
Just like the conventional supply chain management, talent
supply chain management model (TSCM) is an adaptable process
of mobilizing and engaging resources on an as-needed basis,
creating a lean, streamlined system of input and output.
Because it offers oversight as to where talent is sourced,
how it's engaged, and how it performs, TSCM allows companies
to align their talent strategies with organizational objectives,
optimize their workforces, and maximize the potential
of their human capital-all while minimizing superfluous and
inefficient processes. And by engaging vendors and labor
in a manner that's in line with organizational goals, TSCM in
effect creates an integrated or holistic system in which each
part of the supply chain supports the rest. TSCM offers companies significant competitive
advantages, including:
• Enhanced workforce planning.
• Oversight.
• Predictive capability.
• Risk mitigation.
• Access to a broader talent pool.


https://en.wikipedia.org/wiki/Talent_supply_chain_management
https://hbr.org/resources/pdfs/comm/Kelly_OCG/Holistic_Talent_Supply_Chain_Management.pdf
http://knowledge.wharton.upenn.edu/article/talent-on-demand-applying-supply-chain-management-to-people/
https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Process-and-Operations/gx-operations-supply-chain-talent-of-the-future-042815.pdf
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Gram Negative Rod Breast Wound Infections following Post-Cancer Reconstructive Surgery
Donna Mae Pate, John Greene MD

Designing a Model to Explore Tau's Unfolded Protein Response
Lauren Gould, Roy Blackburn, Laura J. Blair

Alterations in Immunophenotype of Autoimmune-prone Hypomorphic RAG-deficient Patients with CID-G/AI Phenotype
Thomas Pennix, Matthew Stowell, Boglarka Ujhazi, Taco Kuijpers, Olajumoke Fadugba, John Sleasman, Benedict Neven, Waleed Al-Herz, Manish Butte, Elisabeth G. Hoyte, Joseph D. Hernandez, Janet S. Chou9, Raif S. Geha, Luigi D. Notarangelo, Eric Meffre, Krisztian Csomos, Jolan E. Walter

Development of Tetrazole Based inhibitor against multple classes of Carbapenemases
Afroza Akhtar

Ligand-independent EphA2 Signaling drives an amoeboid melanoma phenotype that metastasizes to the brain
Chao Zhang1,5, Inna Smalley1, Ritin Sharma2, Michael F. Emmons1, Jane Messina3, John M. Koomen2, Keiran S. M. Smalley1,4*